Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy

Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy

<p>Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death in the young. Acute myocardial ischaemia (a sudden myocardial blood supply/demand mismatch) and pre-existing chronic ionic remodelling (which causes slowed cellular repolarisation) are acknowledged as two key contr...

Bibliografski detalji
Glavni autor:	Coleman, JA
Daljnji autori:	Bueno Orovio, A
Format:	Disertacija
Jezik:	English
Izdano:	2024
Teme:	Computer simulation

Slični predmeti

Files associated with: "Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy"
od: Coleman, J
Izdano: (2024)

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
od: Coleman, JA, i dr.
Izdano: (2023)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
od: Chow, J, i dr.
Izdano: (2024)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
od: Ji-Jian Chow, i dr.
Izdano: (2024-08-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
od: James A. Coleman, i dr.
Izdano: (2024-04-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
od: Coleman, JA, i dr.
Izdano: (2024)

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy
od: Coleman, J, i dr.
Izdano: (2023)

Bridging the Gap Between ECG Indicators of Arrhythmic Risk and the Continuum of Myocardial Disarray and Fibrosis Across Hypertrophic Cardiomyopathy Stages
od: Zakariye Ashkir, MD, i dr.
Izdano: (2024-01-01)

Pro-arrhythmic Electrophysiological Abnormalities in Subclinical and Overt Hypertrophic Cardiomyopathy; Insights from CMR-ECGI
od: George Joy, MD, i dr.
Izdano: (2024-01-01)

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers
od: Lyon, A, i dr.
Izdano: (2018)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
od: Passini, E, i dr.
Izdano: (2015)

Imaging Predictors of Arrhythmic Risk in Genotyped Hypertrophic Cardiomyopathy Patients
od: Safa Daghem, i dr.
Izdano: (2024-01-01)

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study
od: Coleman, JA, i dr.
Izdano: (2024)

Functional assessment of myocardial ischaemia by intracoronary ECG
od: Christian Seiler, i dr.
Izdano: (2021-02-01)

Catheter ablation versus antiarrhythmic drug therapy for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
od: Yan Dong, i dr.
Izdano: (2024-05-01)

Myocardial dysfunction in hypertrophic cardiomyopathy.
od: Ashrafian, H, i dr.
Izdano: (2001)

Adenosine stress T1 mapping: a novel contrast free method to assess myocardial perfusion and ischaemia in hypertrophic cardiomyopathy
od: Raman, B, i dr.
Izdano: (2017)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
od: Raman, B, i dr.
Izdano: (2018)

Computational detection of electrophysiological abnormalities in hypertrophic cardiomyopathy for risk stratification
od: Lyon, A
Izdano: (2017)

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy
od: Kramer, CM, i dr.
Izdano: (2018)

ECG diagnosis of acute ischaemia and infarction: past, present and future.
od: Herring, N, i dr.
Izdano: (2006)

ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY
od: S. M. Komissarova, i dr.
Izdano: (2021-05-01)

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
od: Doste, R, i dr.
Izdano: (2022)

Insights into mechanisms and clinical implications of myocardial fibrosis and its progression in hypertrophic cardiomyopathy
od: Raman, B
Izdano: (2019)

Metabolomics in hypertrophic cardiomyopathy and other myocardial diseases
od: Pal, N
Izdano: (2015)

HYPERTROPHIC CARDIOMYOPATHY AND MYOCARDIAL CRYPT OF THE LEFT VENTRICLE
od: Yu. V. Frolova, i dr.
Izdano: (2017-02-01)

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
od: Dai Qinyi, i dr.
Izdano: (2010-11-01)

Progression of myocardial dysfunction and prediction of arrhythmic events in patients with exercise-induced arrhythmogenic cardiomyopathy
od: Linda T. Aaserud, MD, i dr.
Izdano: (2024-10-01)

Application of cardiac electrophysiology simulations to pro−arrhythmic safety testing
od: Mirams, G, i dr.
Izdano: (2012)

Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing.
od: Mirams, G, i dr.
Izdano: (2012)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
od: K. A. Skiba, i dr.
Izdano: (2003-06-01)

Electrophysiological and anatomical factors determine arrhythmic risk in acute myocardial ischemia and its modulation by sodium current availability
od: Martinez-Navarro, H, i dr.
Izdano: (2020)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
od: Ashrafian, H, i dr.
Izdano: (2003)

An Unusual Presentation of a Myocardial Crypt in Hypertrophic Cardiomyopathy
od: Danny A. J. P. van de Sande, i dr.
Izdano: (2014-01-01)

MYOCARDIAL REMODELLING TYPES IN HYPERTROPHIC NON-OBSTRUCTIVE CARDIOMYOPATHY
od: D. V. Bogdanov
Izdano: (2015-05-01)

The Role of Signalling Pathways in Myocardial Fibrosis in Hypertrophic Cardiomyopathy
od: Patryk Skórka, i dr.
Izdano: (2025-02-01)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study
od: Coppini, R, i dr.
Izdano: (2019)

On the mechanism of the antiarrhythmic action of fabomotizole hydrochloride in alcoholic cardiomyopathy
od: I. A. Miroshkina, i dr.
Izdano: (2021-09-01)

HYPERTROPHIC CARDIOMYOPATHY: MODERN APPROACHES TO DIAGNOSIS AND TREATMENT
od: Elena S. Eniseeva
Izdano: (2024-09-01)

Differential Diagnosis of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
od: M. S. Bychkova, i dr.
Izdano: (2023-10-01)